Section 32
S32 is a venture capital firm investing at the frontiers of technology, healthcare and the life sciences with focus areas including biotechnology, therapeutics, advanced diagnostics, precision medicine, software, cybersecurity, machine learning, and artificial intelligence.
The firm’s goal is to improve the human condition by accelerating the discovery, development, adoption and distribution of important technologies and life saving medicines.
0
0
0
Key Info
- 2017 Founded
- Silicon Valley, California, United States
- 5 Investments
- •••••••••
News
There are no recent news for this organization.
Activity Timeline
Aug 24, 2022
Aug 23, 2022
Apr 02, 2022
Oct 13, 2021
Oct 08, 2017
Team
Investments
Date | Company | Round | Amount | Investors |
|---|---|---|---|---|
Aug 24, 2022 | Venture Round | $23,000,000 | ||
Aug 23, 2022 | Series A | $50,000,000 | ||
Apr 02, 2022 | Venture Round | $5,000,000 | ||
Oct 13, 2021 | Seed | $8,000,000 | ||
Oct 08, 2017 | Series D | $108,100,000 |
